AutoZone, Starbucks and Block fall premarket; Dell, Tesla rise
- S&P 500 and Nasdaq notch highest closes since early 2022
- U.S. economy adds 199,000 jobs in November
- Fed should 'lowball' rate cuts expectations next week says analyst after strong jobs data
- Bernstein's best idea for 2024? Short Tesla stock
- Analysts defend Broadcom as annual guidance falls short after FQ4 earnings beat
Investing.com -- U.S. futures traded marginally higher Tuesday, as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come.
Here are some of the biggest premarket U.S. stock movers today:
Instacart is set to make its Nasdaq debut after the grocery delivery app’s IPO was priced at $30 per share, the top of its indicated price range.
AutoZone (NYSE: AZO) stock fell 2.1% after the auto parts retailer announced disappointing domestic commercial results, overshadowing international strength.
Tesla (NASDAQ: TSLA) stock rose 0.2% after the WSJ reported that the EV manufacturer was in talks with Saudi Arabia to set up a manufacturing facility in the kingdom.
Target (NYSE: TGT) stock rose 0.2% after the retailer said it will hire nearly 100,000 employees for the holiday season and offer deep discounts starting October, as it braces for a competitive shopping period.
Starbucks (NASDAQ: SBUX) fell 1.3% after TD Cowen downgraded the coffee chain to ‘market perform’ from ‘outperform’, citing likely lower consumer spending in China.
Block (NYSE: SQ) stock fell 1.3% after Alyssa Henry, the CEO of the fintech’s unit Square, is set to leave the company after more than nine years.
Dell (NYSE: DELL) stock rose 1.3% after Daiwa Securities upgraded the PC maker to ‘outperform’ from ‘neutral’, citing its strong second quarter numbers as well as growing AI sales.
CVS Health (NYSE: CVS) stock rose 0.9% after Evercore ISI upgraded the drugstore operator to ‘outperform; from ‘in line’, as it sees “operational issues improving and an attractive current valuation."
Boston Scientific (NYSE: BSX) stock rose 0.9% after the medical devices manufacturer agreed to buy Relievant Medsystems, a medical tech company, for $850 million upfront as well as milestone payments.
You May Also Be Interested In
- Midday movers: Lululemon, Paramount and more
- Tesla (TSLA) China plans to build auto research center in Thailand as EVs gain popularity
- Tesla (TSLA) Model Y sold out in China till end of year
Create E-mail Alert Related CategoriesHot List, Investing, Special Reports
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!